The recent advances in membrane protein crystallography have provided extremely valuable structural information of the superfamily of GPCRs (G-protein-coupled receptors). This has been particularly true for a few receptors whose structure was solved several times under different biochemical conditions. It follows that the mechanisms of receptor conformational equilibrium and related dynamic events can be explored by computational simulations. In the present article, we summarize our recent understanding of several dynamic features of GPCRs, accomplished through the use of MD (molecular dynamics) simulations. Our pipeline for the MD simulations of GPCRs, implemented in the web service http://gpcr.usc.es, is updated in the present paper and illustrated by recent applications. Special emphasis is put on the A 2A adenosine receptor, one of the selected cases where crystal structures in several conformations and conditions exist, and on the dimerization process of the CXCR4 (CXC chemokine receptor 4).
Introduction
The function of GPCRs (G-protein-coupled receptors) is governed by a conformational equilibrium between active and inactive states [1, 2] . Understanding the details of this dynamic process is of utmost interest for the GPCR biologists, as well as for the drug design process. The recent advances in receptor stabilization and crystallization [3, 4] have provided invaluable starting points for such characterization, which can be accomplished through the use of experimental techniques such as biophysical mapping or NMR, or by computational simulations. Within the last group, MD (molecular dynamics) is becoming a routine technique to further explore the increasing repertoire of experimental structures, used either alone or in combination with the experimental techniques outlined above [5, 6] . As a consequence, the characterization of dynamic events of several GPCR structures of different families has been considerably improved. We review some of the key recent studies in this category, and further discuss our pipeline for the MD studies of GPCRs with recent examples.
A rise of MD studies of GPCRs
The first crystal structure of the β 2 ADR (β 2 adrenergic receptor) in inactive-like conformation was immediately followed by pioneering long-scale MD simulations from different computational laboratories [7] [8] [9] . These studies demonstrated that the 'ionic lock', a salt bridge between the intracellular tips of TM (transmembrane) 3 and TM6 involving arginine (3.50) and glutamic acid (6.30) , which was unexpectedly absent in the crystal structure, was indeed spontaneously formed and generally stable along the different MD simulations. Analogously, the first crystal structure of the A 2A AR (A 2A adenosine receptor) was simulated in different MD reports, studying the influence of saline concentration in the formation of this ionic lock [10] , the postulated stabilization effect of cholesterol molecules [11] , or the molecular switches that might initiate the activation process [12] . Later reports of GPCR crystal structures even include an initial MD analysis of the given structure: in the case of the D 3 dopamine receptor, an allosteric binding site was proposed by means of partially restrained MD simulations of the ELs (extracellular loops) of this receptor subtype [13] ; whereas in one of the first active-like structures of the β 2 ADR, a long time-scale MD simulation showed a probable pathway for the inactivation process [14] , where the intracellular sides of TM3, TM5 and TM6 approach each other when the receptor goes back to the inactive conformation. It is worth noting that the last simulation was performed in the absence of the intracellular G-protein, which would otherwise act as an allosteric modulator for the stabilization of active conformations of the receptor [15] .
In addition to their complementation with structural biology efforts, MD simulations have a direct impact on structure-based drug design, an approach that is currently exploited by both academia and industry. Thus a method has been proposed to use ensemble docking in virtual screening of aminergic GPCR families [16] , by means of MD sampling of representative receptor conformations. More recently, a proper combination of site-directed mutagenesis, homology modelling, MD simulations and molecular docking has been employed in the design of orexin-1 and -2 receptor antagonists by researchers of Evotec [17] . Finally, it is worth mentioning the use of MD-related techniques for the estimation of free energies in the characterization of GPCR-ligand binding. Some examples include methods such as the classical FEP (free energy perturbation), used in the study of point mutations on the human CCK1R (cholecystokinin 1 receptor) [18] and in the ligand design of 5-HT 4 (serotonin) receptor antagonists [19] , or the LIE (linear interaction energy) method employed for the characterization of interspecies differences in the selectivity of 5-HT 7 receptor ligands [20] . Recently, more demanding computational techniques such as the estimation of PMF (potential of mean force) have allowed the proposal of the entrance pathway for antagonists, as is the case of the β 2 ADR [21] , or even for allosteric modulators such as the sodium ion on the D 2 dopamine receptor [22] .
Given the demonstrable use for MD simulations in the elucidation of receptor function, there is an increasing demand for computational protocols to effectively perform these computational simulations on GPCR systems. On one hand, such protocols should be easy to use to allow for widespread use. On the other hand, they should be accurate and flexible enough to account for the particular conditions of each system under study. Different factors that modulate the dynamics of GPCRs exist: the ligand-binding process, the effect of the specific components of the biological membrane, allosteric modulation or the formation of receptor oligomers. All of these processes are generating great interest in the GPCR research community, and should be considered with care when designing MD studies of these systems.
An automated protocol for the modelling and simulation of GPCRs: GPCR-ModSim and PyMemDyn
Our group has developed a website service that allows allatom MD simulations of a modelled structure of a given receptor, embedded in a membrane model, starting from the receptor sequence [23] . The GPCR-ModSim service (http://gpcr.usc.es), first released in 2011 [24] , is currently being used for research and teaching purposes in several institutions worldwide. The full workflow of this service, outlined in Figure 1 , starts by uploading a FASTA sequence (or alternatively a Uniprot ID) of a GPCR. The server then provides a multiple sequence alignment with all the available templates (currently including 14 inactive-like and seven active-like GPCR crystal structures) and recommends the most homologous template for the homology modelling stage. The user can accept or modify this selection, as well as the sequence alignment itself, and thereafter homology modelling follows using the routines from Modeller [25] . This process is in principle fully automated, although it is flexible enough to allow human intervention in the selection of the best three-dimensional model, i.e. by considering additional experimental information on top of the energetic (DOPEHR scoring function) and stereochemical criteria implemented in the server. An optional stage can follow where selected loop regions are remodelled using the Loopmodel algorithm [26] . The overall performance of our modelling pipeline for GPCR structures was tested for the case of the H 1 histamine receptor with good results, the exact procedure being detailed in our tutorial section (see http://gpcr.usc.es/tutorial). As a further example, homology models of several serotonin and dopamine receptors have been created with GPCR-ModSim and tested for their ability to dock the promiscuous antipsychotic clozapine, as shown in Figure 2 [24] . These models support our previously proposed clozapine-binding mode [27] and offer the possibility of performing multireceptorial profiling in silico, a key step for the design of antipsychotic compounds [28, 29] .
The homology modelling stage outlined above can be skipped if a three-dimensional structure of the receptor of interest is already available, i.e. an experimental (crystal) structure or even a model generated previously by alternative computational methods. In these cases, the user can upload a PDB file of the receptor structure to solely perform the membrane insertion and MD protocol implemented in GPCR-ModSim (see Figure 1) . This module, which we call PyMemDyn, is also available as a stand-alone program upon request. In either of the two possible scenarios (i.e. using our server to generate a homology model or uploading an external three-dimensional structure), this fully automated pipeline allows any researcher, with no prior experience in computational chemistry, to perform the otherwise tedious and complex process of membrane insertion and thorough MD equilibration, as outlined in Figure 1 . In the simplest scenario, only the receptor structure is considered. This will be automatically embedded in a pre-equilibrated POPC (1-palmitoyl-2-oleoyl phosphatidylcholine) membrane model so that the TM bundle is parallel to the vertical axis of the membrane. The system is then soaked with bulk water and inserted into a hexagonal prism-shaped box that is energy-minimized and carefully equilibrated in the framework of PBC (periodic boundary conditions). It then follows a MD equilibration protocol that lasts 2.5 ns, as described in more detail in recent publications [12, 30] . However, the simulation of an isolated receptor can only account for one part of the problem, and the influence of different non-protein elements in receptor dynamics such as an orthosteric ligand, an allosteric modulator, or even specific cholesterol, lipid, water or ion molecules should be considered for a more comprehensive characterization of GPCRs. To allow for a broader use of MD simulations to researchers in the field, PyMemDyn can explicitly handle these elements. Each molecule should be uploaded as docked to the original PDB file of the receptor, so they are properly integrated into the membrane insertion protocol described above, together with the force-field associated files [which can either be generated with external software such as Macromodel, version 9.7 (http://www.schrodinger.com/), or by manual parameterization]. In addition, it is also possible to perform MD simulations of receptor dimers, provided The blue squares represent the MD simulation protocol, which is also available as a separate module. SPC, simple point charge. POPC, 1-palmitoyl-2-oleoyl phosphatidylcholine.
that a proper dimerization model exists, i.e., coming from Xray crystallography [32] or from a protein-protein docking protocol. The ease of use, flexibility and public availability of the PyMemDyn module makes it a unique tool for researchers in the GPCR field interested in exploring the structure and/or dynamic processes of these receptors.
Exhaustive MD simulations of the A 2A AR
The family of ARs is composed of four members, namely A 1 , A 2A , A 2B and A 3 , which mediate the signal transduction of extracellular adenosine [33] . The four receptors are ubiquitously distributed in the body, with different signalling functions and tissue distributions, and mediate several physiological functions [34] . Consequently, ARs are implicated in a large number of pathologies and have been recognized as potential drug targets. In particular, the A 2A AR is involved in cardiovascular diseases such as hypertension or atherosclerosis [35] ; CNS (central nervous system) pathologies such as Parkinson's disease, through the heterodimerization with D 2 dopamine receptor [36] ; and several inflammatory processes, since the A 2A AR is the body's last resort in severe inflammatory conditions [33, 37] . In addition to this pharmaceutical interest, and partially as a consequence of it, this receptor has been the target of extensive structural biology studies and at present, the A 2A AR is one of the best-characterized GPCRs at the molecular level. Table 1 summarizes all the experimental structures of this receptor solved to date. From the first crystal structure, released in 2008 in complex with the classic antagonist ZM241385 [38] , to the very recent structure of this same complex at a high atomic resolution [39] , this receptor has been trapped in distinct functional states employing different strategies for crystallization. Both active- [40, 41] or inactive-like [38, 39, 42, 43] conformations are available, including structures used in the development of drug candidates now in clinical trials [44] . Recently, a 1.8 Å (1 Å =0.1 nm) resolution structure of inactive A 2A AR in complex with ZM241385 was obtained by fusion with a thermostabilized BRIL (apocytochrome b562RIL) [39] . This structure is particularly exciting as it reveals the precise location of several non-protein elements that might be implicated in receptor stability and/or that have allosteric effects, namely: (i) a sodium ion bound to a GPCR-conserved binding crevice; (ii) two cholesterol-binding sites in the external side of TM3 and TM6; (iii) a lipid molecule in the extracellular interhelical space between TM1 and TM7; and (iv) several novel structural water molecules.
Our flexible MD protocol for GPCRs allows us to take all this variability into account and explore the effect of some [44] of the variable elements in the different A 2A AR structures as outlined in Figure 3 . On the basis of the first crystal structure of A 2A AR, we performed parallel simulations to study how the conformational equilibrium of the receptor is affected by elements such as crystallographic water molecules, the antagonist ligand or the charged state of key histidine residues [12] . Interestingly, the residence time for water molecules in the region connecting TM1, TM2 and TM7 was found to be higher than average, regardless of the inclusion of crystal water molecules in the MD set-up. This is in agreement with the structural role proposed for water molecules in that particular region [45] and showed the predictive power of MD simulations, since the bulk solvent could successfully occupy the hydration site of the crystal waters when these were absent in the initial set-up. In the later high-resolution structure (see Table 1 ), this water cluster was indeed defined as a sodium-binding site where water molecules contribute to the proper co-ordination of the ion [39] , and was further analysed by us, together with the influence of additional structural elements (H. Gutiérrez-de-Terán, A. Massink, D. Rodríguez, W. Liu, J.S. Joseph, I. Katritc, L.H. Heitman, L. Xiac, A.P. IJzerman, V. Cherezov, V. Katritch and R.C. Stevens, unpublished work). Regarding the conformational role of particular residues, we proposed the most probable charge state of two key histidine residues, by performing parallel simulations considering either charged or neutral histidine residues [12] . Interestingly, we found that a charged histidine (7.29) residue in the EL3 would importantly contribute to a reduced mobility of the ELs, especially together with a charged histidine (7.43) residue, by establishing a salt bridge interaction with glutamate (5.30) in EL2 that kept the extracellular lid in a 'closed' state. Since this glutamate is hydrogen-bonded to the amine group of both agonists and many antagonists (such as the co-crystallized ZM241385), we also examined with parallel simulations the influence of the ligand in this structural element, finding that the charged state of the histidine residue was particularly important to maintain the ligand in the binding site. This prediction was later confirmed by the 1.8 Å structure [39] , where a charged state of histidine (7.29) can be unambiguously assigned on the basis of interactions with the oxygen atoms of glutamate (5.30) and the main chain of alanine (7.30) in EL3. Our compared MD simulations, in this case with the related A 2B AR [12] , also suggested an important role of this residue in the kinetics of the ligand-binding process, on the basis of an enhanced flexibility in the EL region of the A 2B AR, which has a neutral asparagine residue instead of histidine and is considered a low-affinity receptor for the natural agonist [33] .
The study of a GPCR homodimer: the CXCR4 (CXC chemokine receptor 4) case
A phenomenon of increasing interest in the field of GPCR research is the growing evidence of dimerization and oligomerization processes in receptor function. The first semi-empirical structural evidence of a receptor dimer was based on the AFM (atomic force microscopy) map of rhodopsin [46] , which involved the interaction of TM4 and TM5 between protomers and constituted the most accepted GPCR dimerization model for several years. The crystal structures of the CXCR4 with different antagonists, released in 2010 [32] , presented a novel GPCR dimerization interface where the main hydrophobic interactions involved TM5-TM5 contacts, and hydrogen bonds between the extracellular tips of TM5 and TM6 of each protomer. This dimerization model resulted in a significant buried surface area (≈850 Å 2 ) and suggested a potential biological relevance of the observed dimerization mode of CXCR4. It should be noted that these structures were crystallized in the LCP (lipid cubic phase) using receptor constructs that contained stabilizing mutations and the T4L (T4 lysozyme) protein fusion method, and that two slightly different models were presented (i.e., cocrystallized with a small antagonist or with a cyclic peptide). Thus we decided to further explore the biological significance and structural characterization of this dimerization model with our MD simulation protocols.
Extensive MD simulations of the apo forms of the two crystallographic models were performed, considering in each case either the stabilized mutant crystallographic form or the wild-type receptor [30] . In this respect, our MD simulations showed punctal distortions on the wild-type protomers, thus justifying the observed increased thermal stability of the mutant forms. The simulations support the dimerization mode observed in both crystal structures (PDB codes 3ODU and 3OE0), since the position of the protomers remained stable with respect to the initial pose, although certain rearrangements in the relative orientation of protomers were observed: the buried surface area of the dimerization interface grew in all cases, mainly driven by the native hydrophobic interactions between the receptors. The conformational changes were more significant for the case of the dimer co-crystallized with the small molecule inhibitor, owing to the lower initial contacts in the intracellular half of the dimerization interface compared with the structure with the cyclic peptide [32] . We concluded that the relatively high buried surface area between the intracellular T4L fusion proteins present in the former crystal model might induce a bias in its initial conformation, justifying the observed conformational changes. This behaviour is also in line with the observations reported in the recent structure of the μ-OR (μ-opioid receptor) [47] , which further supports the relevance of the TM5-TM6 interface observed for CXCR4 structures. Given the transient nature of GPCR dimers, this computational evaluation significantly explores expectable structural rearrangements from the crystallographic structures of CXCR4, in agreement with the ligand-independent dimerization of this receptor [48] , concluding that the interface of the cyclic peptide-bound homodimer structure (PDB code 3OE0) presents a reliable high-resolution depiction of GPCR dimerization.
Conclusions
We have reviewed the capacities of our computational protocol to explore the architecture and dynamics of GPCRs. This protocol is available for any researcher in the field without previous experience in computational methods, through a web-based service open to the scientific community. Particular emphasis is put on the effect that different elements in the receptor environment might have on its structure and dynamics, with functional and pharmacological implications. These include the presence of either orthosteric or allosteric ligands, particular components of the biological membrane or the inclusion of structural water molecules. In addition, the conformation of the receptor, the effect of point mutations or the oligomerization process can also be considered with our automated MD protocol. The implementation of this protocol has been illustrated with recent examples in the investigation of A 2A AR of the conformational equilibrium of A2AAR or the CXCR4 dimerization process, but is equally useful in the study of any other GPCR. 
